1 |
Show member pathways
|
14.08 |
U2AF1 TP53 PTEN PPP2R1A MSH2 MLH1 |
2 |
Show member pathways
|
13.99 |
TP53 PTEN PPP2R1A PIK3CA KRAS ICOSLG |
3 |
|
13.78 |
CD274 CTNNB1 ERBB2 FBXW7 H2AC18 HRAS |
4 |
Show member pathways
|
13.68 |
TP53 PTEN PPP2R1A PIK3CA MSH6 MSH2 |
5 |
Show member pathways
|
13.53 |
CD274 CD8A FBXW7 HRAS ICOSLG KRAS |
6 |
Show member pathways
Development Prolactin receptor signaling
22
ErbB Family Pathway
64
ErbB2-ErbB3 Heterodimers
64
ErbB4 Pathway
64
Glioblastoma Multiforme
64
Growth Hormone Signaling
64
HMGB1 Pathway
64
IL-2 Pathway
64
LPS Stimulated MAPK Signaling
64
PACAP Signaling
64
PI3K Signaling in B-Lymphocyte
64
Thrombopoietin Pathway
64
TREM1 Pathway
64
UVA-Induced MAPK Signaling
64
UVB-Induced MAPK Signaling
64
UVC-Induced MAPK Signaling
64
|
13.49 |
CTNNB1 ERBB2 HRAS KRAS MSH6 PIK3CA |
7 |
Show member pathways
|
13.38 |
PTEN PPP2R1A PIK3CA KRAS HRAS FBXW7 |
8 |
Show member pathways
|
12.97 |
TP53 PTEN PPP2R1A PIK3CA KRAS HRAS |
9 |
Show member pathways
Fc-EpsilonRI Pathway
64
ITK and TCR Signaling
64
PDGF Pathway
64
PKC-Theta Pathway
64
|
12.94 |
TP53 MSH6 MSH2 MLH1 KRAS HRAS |
10 |
Show member pathways
IGF1R Signaling
64
Signaling Involved in Cardiac Hypertrophy
64
|
12.88 |
PTEN PIK3CA KRAS HRAS ERBB2 |
11 |
|
12.85 |
PPP2R1A PIK3CA KRAS HRAS ERBB2 CTNNB1 |
12 |
|
12.72 |
TP53 PTEN PIK3CA HRAS CTNNB1 CD274 |
13 |
Show member pathways
DNA Repair Mechanisms
64
Estrogen-mediated S-Phase Entry
64
G2-M Phase Transition
64
SREBP Proteolysis
64
|
12.62 |
FBXW7 MSH2 MSH6 POLE TP53 |
14 |
|
12.53 |
MLH1 MSH2 MSH6 PPP2R1A TP53 |
15 |
Show member pathways
Angiopoietin-TIE2 Signaling
64
Development Angiopoietin - Tie2 signaling
22
Development PDGF signaling via STATs and NF-kB
22
Immune response IL-10 signaling pathway
22
|
12.53 |
CTNNB1 ERBB2 HRAS KRAS MSH2 PIK3CA |
16 |
Show member pathways
Apoptosis and survival Anti-apoptotic action of membrane-bound ESR1
22
Apoptosis and survival NGF signaling pathway
22
Apoptosis and survival Role of CDK5 in neuronal death and survival
22
Development HGF signaling pathway
22
Development Neurotrophin family signaling
22
|
12.48 |
TP53 PTEN PIK3CA HRAS ERBB2 CTNNB1 |
17 |
Show member pathways
Development ERBB-family signaling
22
EGF Pathway
64
|
12.47 |
TP53 PIK3CA KRAS HRAS ERBB2 CTNNB1 |
18 |
Show member pathways
Signal transduction PTEN pathway
22
|
12.47 |
CTNNB1 ERBB2 HRAS KRAS MLH1 MSH2 |
19 |
Show member pathways
|
12.46 |
TP53 PIK3CA KRAS HRAS ERBB2 CTNNB1 |
20 |
Show member pathways
Cell cycle Transition and termination of DNA replication
22
Mismatch Repair in Eukaryotes
64
|
12.44 |
MLH1 MSH2 MSH6 POLE |
21 |
Show member pathways
Development VEGF signaling and activation
22
|
12.42 |
PIK3CA KRAS HRAS CTNNB1 |
22 |
Show member pathways
Cytoskeleton remodeling CDC42 in cellular processes
22
|
12.41 |
CTNNB1 ERBB2 HRAS KRAS PIK3CA |
23 |
Show member pathways
|
12.38 |
PPP2R1A PIK3CA ICOSLG CTNNB1 CD8A CD274 |
24 |
Show member pathways
|
12.34 |
PTEN PIK3CA KRAS HRAS |
25 |
Show member pathways
|
12.34 |
PIK3CA KRAS HRAS CTNNB1 |
26 |
|
12.32 |
PTEN PIK3CA HRAS ERBB2 CTNNB1 |
27 |
Show member pathways
|
12.3 |
TP53 PTEN PIK3CA KRAS HRAS ERBB2 |
28 |
Show member pathways
|
12.29 |
PPP2R1A PIK3CA KRAS HRAS |
29 |
Show member pathways
Immune response IL-4 signaling pathway
22
Signal transduction AKT signaling
22
|
12.28 |
TP53 PTEN PIK3CA HRAS |
30 |
Show member pathways
|
12.27 |
PIK3CA KRAS HRAS ERBB2 |
31 |
Show member pathways
|
12.25 |
ERBB2 HRAS KRAS PIK3CA PTEN TP53 |
32 |
|
12.22 |
CTNNB1 HRAS KRAS PIK3CA TP53 |
33 |
Show member pathways
|
12.18 |
TP53 PTEN PIK3CA HRAS CD8A |
34 |
Show member pathways
Translation Non-genomic (rapid) action of Androgen Receptor
22
|
12.16 |
PTEN PIK3CA HRAS ERBB2 CTNNB1 |
35 |
|
12.12 |
TP53 PTEN KRAS ERBB2 |
36 |
Show member pathways
|
12.1 |
PIK3CA KRAS HRAS ERBB2 |
37 |
|
12.1 |
CTNNB1 KRAS MLH1 MSH2 MSH6 TP53 |
38 |
|
12.08 |
TP53 PTEN MSH2 MLH1 |
39 |
Show member pathways
|
12.06 |
PIK3CA KRAS HRAS ERBB2 |
40 |
|
12.02 |
TP53 PTEN MSH6 MSH2 KRAS CTNNB1 |
41 |
|
12 |
PIK3CA KRAS HRAS CTNNB1 |
42 |
Show member pathways
Development EGFR signaling via PIP3
22
Development PDGF signaling via MAPK cascades
22
|
11.98 |
ERBB2 HRAS KRAS PIK3CA PTEN |
43 |
Show member pathways
|
11.88 |
PIK3CA KRAS HRAS |
44 |
Show member pathways
|
11.86 |
PIK3CA KRAS HRAS |
45 |
|
11.86 |
TP53 PIK3CA HRAS CTNNB1 |
46 |
|
11.85 |
TP53 POLE MSH6 |
47 |
Show member pathways
Fanconi's Anaemia Pathway
64
|
11.84 |
TP53 MSH6 MSH2 |
48 |
Show member pathways
|
11.84 |
TP53 PIK3CA KRAS HRAS |
49 |
|
11.82 |
TP53 MSH2 MLH1 |
50 |
Show member pathways
|
11.81 |
PIK3CA KRAS HRAS |